Substituted benzylaminoalkylene heterocycles

Details for Australian Patent Application No. 2004283816 (hide)

Owner Newron Pharmaceuticals S.p.A.

Inventors Melloni, Piero; Sabido David, Cibele; Salvati, Patricia; Vallese, Stefania; Restivo, Alessandra; Caccia, Carla

Agent Lord and Company

Pub. Number AU-B-2004283816

PCT Pub. Number WO2005/040138

Priority 03023342.3 15.10.03 EP

Filing date 5 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 16 July 2009

International Classifications

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 235/14 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 249/02 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 261/02 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/10 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/14 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/38 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/81 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 309/04 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 319/12 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 327/04 (2006.01) Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 235/10 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040138 Priority application(s): WO2005/040138

16 July 2009 Application Accepted

  Published as AU-B-2004283816

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283821-Diazabicyclononene derivatives and their use as renin inhibitors

2004283814-Tetrahydropyridine derivatives